Full Press Release Details
COMPANY ANNOUNCEMENT
Notice under Section 708A (5) of the
17th September 2012:
This notice is given under paragraph (5)(e) of section 708A
of the Corporations Act.
The following securities of the Company are issued without disclosure
to investors under Part 6D.2 of the Corporations Act:
| Type: | Ordinary Shares |
| Class/Description: | Ordinary Fully Paid Shares |
| ASX Code: | PBT |
| Date of Issue: | 14th, 17th and 18th September 2012 |
| Number Issued: | 4,111,560 |
| Issue Price | AUD$ 822,879 |
The Company has applied to ASX Limited for quotation of the
As at the date of this notice, the Company has complied with:
For and on behalf of Prana Biotechnology Ltd,
Prana Biotechnology Limited
2.7, 3.10.3, 3.10.4, 3.10.5
New issue announcement,
application for quotation of additional
or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's
property and may be made public.
1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.
| Name of Entity: |
| Prana Biotechnology Limited (ASX:PBT) |
| ABN: |
| 37 080 699 065 |
(the entity) give ASX the following information.
must complete the relevant sections (attach sheets if there is not enough space).
| 1 | + Class of + securities issued or to be issued | Ordinary Shares |
| 2 | Number of + securities issued or to be issued (if known) or maximum number which may be issued | 4,111,560 |
| 3 | Principal terms of the + securities (eg, if options, exercise price and expiry date; if partly paid + securities, the amount outstanding and due dates for payment; if + convertible securities, the conversion price and dates for conversion) | Pari passu with existing Ordinary Shares (PBT) |
| 4 | Do the + securities rank equally in all respects from the date of allotment with an existing + class of quoted + securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | Yes (PBT) |
| 5 | Issue price or consideration | AUD$822,879 |
| 7 | Dates of entering + securities into uncertificated holdings or despatch of certificates | 14 th ,17 th and 18 th September 2012 | |
| Number | +Class | ||
| 8 | Number and + class of all + securities quoted on ASX ( including the securities in clause 2 if applicable) | 306,662,168 | Ordinary Shares (PBT) |
of all +securities not quoted on ASX (including the securities in clause 2 if applicable)
| ASX Code | Number | Class of Securities | Issued under an ESOP | ||
| Security Type | Exercise Price | Expiry Date | |||
| PBTAB | 2,270,690 | Unlisted Options | $Nil | 7 Aug 2014 | 2004 ASX Plan |
| PBTAI | 8,512,645 | Unlisted Options | AUD$0.225 | 24 Mar 2015 | - |
| PBTAK | 380,000 | Unlisted Options | US$5.00 per option into 1 ADR (PRAN) (1 ADR = 10 Ordinary Shares (PBT)) | 17 Dec 2012 | 2004 US ADS Plan |
| PBTAM | 10,000,000 | Unlisted Options | AUD$0.30 | 11 Sep 2013 | - |
| PBTAO | 612,397 | Unlisted Options | AUD$0.17 | 24 Feb 2016 | - |
| PBTAQ | 3,500,000 | Unlisted Options | AUD$0.30 | 23 Sep 2012 | - |
| PBTAS | 1,418,756 | Unlisted Options | AUD$0.15 | 31 Mar 2014 | 2004 ASX Plan |
| PBTAU | 1,000,000 | Unlisted Options | AUD$0.25 | 19 Dec 2014 | 2004 ASX Plan |
| PBTAW | 1,658,237 | Unlisted Options | AUD$0.25 | 20 Mar 2017 | 2004 ASX Plan |
| TOTAL | 29,352,725 |
Part 2 - Bonus issue or pro rata
| 11 | Is security holder approval required? | |
| 12 | Is the issue renounceable or non-renounceable? | |
| 13 | Ratio in which the + securities will be offered | |
| 14 | +Class of +securities to which the offer relates | |
| 15 | +Record date to determine entitlements | |
| 16 | Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? | |
| 17 | Policy for deciding entitlements in relation to fractions | |
| 18 | Names of countries in which the entity has + security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. | |
| 19 | Closing date for receipt of acceptances or renunciations | |
| 20 | Names of any underwriters | |
| 21 | Amount of any underwriting fee or commission | |
| 22 | Names of any brokers to the issue | |
| 23 | Fee or commission payable to the broker to the issue | |
| 24 | Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of + security holders |
| 25 | If the issue is contingent on + security holders' approval, the date of the meeting | |
| 26 | Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled | |
| 27 | If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders | |
| 28 | Date rights trading will begin (if applicable) | |
| 29 | Date rights trading will end (if applicable) | |
| 30 | How do + security holders sell their entitlements in full through a broker? | |
| 31 | How do + security holders sell part of their entitlements through a broker and accept for the balance? | |
| 32 | How do + security holders dispose of their entitlements (except by sale through a broker)? | |
| 33 | + Despatch date |
Part 3 - Quotation of securities
You need only complete this section
if you are applying for quotation of securities
| 34 | Type of securities ( tick one ) | |
| (a) | Securities described in Part 1 |
Entities that have ticked box 34(a)
Additional securities forming a new
| 35 | If the + securities are + equity securities, the names of the 20 largest holders of the additional + securities, and the number and percentage of additional + securities held by those holders | |
| 36 | If the + securities are + equity securities, a distribution schedule of the additional + securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over | |
| 37 | A copy of any trust deed for the additional + securities |
Entities that have ticked box 34(b)
| 38 | Number of securities for which + quotation is sought | |
| 39 | Class of + securities for which quotation is sought |
| 40 | Do the + securities rank equally in all respects from the date of allotment with an existing + class of quoted + securities? If the additional securities do not rank equally, please state: - the date from which they do - the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment - the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | |
| 41 | Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security) |
| Number | +Class | ||
| 42 | Number and + class of all + securities quoted on ASX ( including the securities in clause 38) |
entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
| Sign Here: | Date: Monday 17 th September 2012 | |
| Company Secretary |
Name: Mr Richard Revelins